Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, Celico C, Falautano M, Nonis A, La Rosée P, Binder M, Fabbri A, Ilariucci F, Krampera M, Roth A, Hemmaway C, Johnson PW, Linton KM, Pukrop T, Gørløv JS, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Zanni M, Krause SW, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Thurner L, Cabras G, Pennese E, Ponzoni M, Deckert M, Politi LS, Finke J, Ferranti A, Cozens K, Burger E, Ielmini N, Cavalli F, Zucca E, Illerhaus G; IELSG32 study investigators. Ferreri AJM, et al. Among authors: ferranti a. Leukemia. 2022 Jul;36(7):1870-1878. doi: 10.1038/s41375-022-01582-5. Epub 2022 May 13. Leukemia. 2022. PMID: 35562406 Clinical Trial.
Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi.
Zaja F, Ferrero S, Stelitano C, Ferrari A, Salvi F, Arcari A, Musuraca G, Botto B, Spina M, Cellini C, Patti C, Liberati AM, Minotto C, Pileri SA, Ceccarelli M, Volpetti S, Ferranti A, Drandi D, Montechiarello E, Ladetto M, Carmichael J, Fanin R. Zaja F, et al. Among authors: ferranti a. Haematologica. 2017 May;102(5):e203-e206. doi: 10.3324/haematol.2016.154211. Epub 2017 Jan 12. Haematologica. 2017. PMID: 28082342 Free PMC article. Clinical Trial. No abstract available.
Microbial metabolomics' latest SICRIT: Soft ionization by Chemical Reaction in-Transfer mass spectrometry.
McAtamney A, Ferranti A, Ludvik DA, Yildiz FH, Mandel MJ, Hayward T, Sanchez LM. McAtamney A, et al. Among authors: ferranti a. bioRxiv [Preprint]. 2024 Jul 18:2024.07.17.604007. doi: 10.1101/2024.07.17.604007. bioRxiv. 2024. Update in: J Am Soc Mass Spectrom. 2024 Sep 29. doi: 10.1021/jasms.4c00309 PMID: 39071417 Free PMC article. Updated. Preprint.
Trofinetide: a pioneering treatment for Rett syndrome.
Parent H, Ferranti A, Niswender C. Parent H, et al. Among authors: ferranti a. Trends Pharmacol Sci. 2023 Oct;44(10):740-741. doi: 10.1016/j.tips.2023.06.008. Epub 2023 Jul 16. Trends Pharmacol Sci. 2023. PMID: 37460385 Free PMC article.
Acute alcohol and chronic drinking bidirectionally regulate the excitability of prefrontal cortex vasoactive intestinal peptide interneurons.
Thompson SM, Ferranti AS, Joffe ME. Thompson SM, et al. Among authors: ferranti as. bioRxiv [Preprint]. 2023 Mar 10:2023.03.07.531614. doi: 10.1101/2023.03.07.531614. bioRxiv. 2023. Update in: Neuropharmacology. 2023 Nov 1;238:109638. doi: 10.1016/j.neuropharm.2023.109638 PMID: 36945582 Free PMC article. Updated. Preprint.
74 results